Keebeck Wealth Management

Position in CPRX — Catalyst Pharmaceuticals, Inc.

CIK 1803675 Chicago, IL

Position in CPRX

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$623,357

+$85,907 QoQ

Shares Held

25,176

+9.3% QoQ

Ownership

0.021%

of shares outstanding

% of Portfolio

0.17%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2025

5 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Keebeck Wealth Management holds $1,033,322 across 3 Biotechnology names. CPRX ranks #1 (60.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CPRX	Catalyst Pharmaceuticals, Inc. This page	25,176	$623,357
2	ADMA	Adma Biologics, Inc.	35,459	$319,485
3	RLMD	Relmada Therapeutics, Inc.	13,000	$90,480

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$623,357	25,176	+9.3%	Shares	Other	2026-05-14
2025-12-31	$537,450	23,027	+29.5%	Shares	Other	2026-02-17
2025-09-30	$350,305	17,782	-12.9%	Shares	Other	2025-11-14
2025-06-30	$443,265	20,427	+119.6%	Shares	Other	2025-08-14
2025-03-31	$225,525	9,300	—	Shares	Other	2025-05-15
No filing history on record for this holder in this stock.